SALT LAKE CITY--(BUSINESS WIRE)--BSD Medical Corporation (NASDAQ:BSDM) (Company or BSD) (www.BSDMedical.com), a leading provider of medical systems that utilize heat therapy to treat cancer, announced today that the Company has received a purchase order from Dr. Sennewald Medizintechnik GmbH for a BSD-2000/3D/MR Image Guided Hyperthermia System (BSD-2000/3D/MR) that will be installed at the Erasmus MC Cancer Institute, location Daniel den Hoed. The BSD-2000/3D/MR system integrates a BSD-2000/3D Hyperthermia System with Magnetic Resonance (MR) imaging to deliver targeted image guided hyperthermia therapy, while simultaneously providing non-invasive imaging of the diseased tissue as well as the surrounding healthy tissue. The magnetic resonance images are color graded to show temperature changes in the treatment area during hyperthermia therapy.